Page 614 - Traité de chimie thérapeutique 6 Médicaments antitumoraux

574 ANT7METABOLITES

BENEZRA S.A., FOSS P .R.B., 6-mercaptopurine, in Analytical Profiles of Drugs Substan-
ces, FLOREY K., ed. Academic Press, New York, 1978, vol. 7, 343-357.
SITTING M., Mercaptopurine in Pharmaceutical Manufacturing Encyc/opedia, Noyes
Data Corporation ed., Park Ridge, New Jersey, 1979, 393-394.
ELION G.B., Historical background of 6-mercaptopurine, Toxicol. and lnd. Health, 1986,
2, 1-9.
VAN SCOIK K.G., et al., The pharmacology and metabolism of the thiopurine drugs
6-mercaptopurine and azathioprine, Drug Metabolism Reviews, 1985, 16, 157-174.
RUDY J.L., et al., HPLC analysis of 6-mercaptopurine and metabolites in extracellular
bodyfluids, Ann. Clin. Biochem., 1988, 25, 504-509.
LENNARD L., The clinical pharmacology of 6-mercaptopurine, Eur. J. Clin. Pharmacol.,
1992, 43, 329-339.
HARTKE K., SCHÂFER-KORTING M., Mercaptopurin, Kommentar zum DAB 10, 1994,
4, M45, 1-4.
AARBAKKE J. et al., Thiopurine biology and pharmacology, TIPS, 1997, 18,3-7.
JACOZ-AIGRAIN E., et al., Pharmacokinetics and distribution of 6-mercaptopurine
administered intravenously in children with lymphoblastic leukaemia, Eur. J. Clin.
Pharmacol., 1997, 53, 71-74.
LOWE E.S. et al., Plasma pharmacokinetics and cerebrospinal fluid penetration of thio-
guanine in children with acute lymphoblastic leukemia : a collaborative pediatric onco-
logy branch, NCI, and children's cancer group study, CancerChemother. Pharmacol.,
2001, 47, 199-205.
PENTOSTATINE
WOO P.W.K., DION H.W., A novel adenosine and ara-A deaminase inhibitor, (R)-3-(2-
deoxy-B-D-erythro-pentofuranosyl-3,6,7,8-tetrahydroimidazo [4,5-d][1,3] diazepin-8-
ol, J. Heterocyclic Chem., 1974, 11, 641-643.
McCONNEL W.R. et al., Pharmacokinetics of 2'-deoxycoformycin in normal and L1210
leukemic mice, Amer. Soc. Pharmacol. Experiment. Ther., 1979, 7, 11-13.
SMYTH J.F. et al., The clinicat pharmacology of the adenosine deaminase inhibitor 2'-
deoxycoformycin, Cancer Chemother. Pharmacol., 1980, 5, 93-101.
CHAN E. et al., Total synthesis of (8/3)-3-(2-deoxy--D-erythro-pentofuranosyl)-3,6,7,8-
tetrahydroimidazo (4,5-c/][1,3) diazepin-8-ol, (Pentostatin), the potent inhibitor of ade-
nosine deaminase, J. Org. Chem., 1982, 47, 3457-3464.
CUMMINGS F.J. et al., Clinical, pharmacologie, and immunologie effects of 2'-deoxyco-
formycin, Clin. Pharmacol. Ther., 1988, 44, 501-509.
JOHNSON J.B. et al., Efficacy of 2'-deoxycoformycin in hairy-cell leukemia: a study of
the National Cancer lnstitute of Canada clinical trials group, J. Nat. Cane. lnst., 1988,
80, 765-769.
WYETH-LEDERLE, Nipent-pentostatine, Traitement de la leucémie à tricholeucocytes,
1-36.
THIOGUANINE
SITTIG M., Thioguanine, in Pharmaceutical Manufacturing Encyclopedia, Noyes Data
Corporation ed., Park Ridge, New Jersey, 1979, 599.